12:00 AM
Nov 22, 1999
 |  BC Week In Review  |  Company News  |  Deals

InSite, Pharmacia & Upjohn deal

P&U acquired an exclusive license to diagnostic and prognostic applications of ISV's ISV-900 test for genetic markers of...

Read the full 80 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >